ArticleFrontiers in oncology2020

Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study.

Muhammad A Khattak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.